Classification | Variable | Treatment | Group | Treadmill periods | |||
---|---|---|---|---|---|---|---|
1st | 2nd | 3rd | 4th | ||||
Cardiorespiratory fitness | HR (b∙min−1)*† | Caffeine | HCF | 152.88 ± 10.70 | 159.02 ± 10.62 | 157.49 ± 14.53 | 172.18 ± 6.76 |
MCF | 159.01 ± 11.86 | 163.22 ± 11.71 | 161.13 ± 13.33 | 173.30 ± 15.42 | |||
Placebo | HCF | 150.97 ± 11.99 | 156.84 ± 11.14 | 150.88 ± 12.49 | 160.03 ± 7.24 | ||
MCF | 151.43 ± 16.59 | 161.44 ± 12.28 | 159.50 ± 11.59 | 163.20 ± 20.05 | |||
RPE*† | Caffeine | HCF | 10.00 ± 1.51 | 11.67 ± 2.28 | 11.70 ± 2.29 | 14.67 ± 1.93 | |
MCF | 11.23 ± 0.98 | 13.03 ± 1.34 | 13.47 ± 1.57 | 15.23 ± 1.66 | |||
Placebo | HCF | 10.37 ± 1.71 | 12.33 ± 2.15 | 12.97 ± 1.58 | 15.53 ± 1.34 | ||
MCF | 11.20 ± 1.03 | 13.30 ± 1.70 | 14.43 ± 1.49 | 16.60 ± 1.55 | |||
Neuromuscular fitness | HR (b∙min−1)*† | Caffeine | HNF | 155.28 ± 13.33 | 163.76 ± 14.14 | 159.70 ± 17.36 | 178.54 ± 10.39 |
MNF | 156.61 ± 9.86 | 158.49 ± 6.66 | 158.91 ± 9.72 | 168.22 ± 11.73 | |||
Placebo | HNF | 155.00 ± 11.25 | 158.16 ± 12.42 | 157.70 ± 2.12 | 167.19 ± 10.40 | ||
MNF | 147.40 ± 16.15 | 160.12 ± 11.42 | 152.69 ± 13.07 | 156.04 ± 16.82 | |||
RPE*† | Caffeine | HNF | 10.53 ± 1.64 | 11.83 ± 1.96 | 11.83 ± 2.25 | 14.30 ± 1.16 | |
MNF | 10.70 ± 1.17 | 12.87 ± 1.89 | 13.33 ± 1.77 | 15.60 ± 2.09 | |||
Placebo | HNF | 10.63 ± 1.65 | 12.27 ± 1.57 | 13.10 ± 1.56 | 15.47 ± 1.22 | ||
MNF | 10.93 ± 1.26 | 13.37 ± 2.21 | 14.30 ± 1.64 | 16.47 ± 1.60 |